Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report

Journal of Medical Case Reports

Volumn 10, Issue 1, 2016, Pages 1-5

  Schiavoni, Mario ^a   Coluccia, Antonella ^a  

^a Hemophilia and Rare Coagulopathies Centre ^*  (Italy)

Author keywords

Case report; Postoperative deep venous thrombosis; Rivaroxaban; Warfarin

Indexed keywords

ANTIVITAMIN K; D DIMER; ENOXAPARIN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CAUCASIAN; COMPRESSION STOCKING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG EDEMA; MOBILIZATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; SAPHENECTOMY; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN INSUFFICIENCY; DRUG ADMINISTRATION; LOWER LIMB; POSTOPERATIVE COMPLICATIONS; VASCULARIZATION; VENOUS THROMBOSIS;

ADULT; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOWER EXTREMITY; POSTOPERATIVE COMPLICATIONS; RIVAROXABAN; TREATMENT OUTCOME; VENOUS THROMBOSIS; WARFARIN;

EID: 84991293700     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/s13256-016-1058-5     Document Type: Article

References (13)

1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835-46.
2. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S-94.
3. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-64.
4. Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361:2342-52.
5. EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499-510.
6. EINSTEIN-PE Investigators, Büller HR, Prins MH, Lensin AWA, Decousus H, Jacobson BF, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287-97.
7. Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369:1406-15.
8. Hillis CM, Crowther MA. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2015;113:1193-202.
9. Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013;11:21.
10. Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383:880-8.
11. Simon McRae. Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J. 2014;12(1):27.
12. Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood. 2012;119:3016-23.
13. Kubitza D, Becka M, Mück W, Krätzschmar J. Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects. Br J Clin Pharmacol. 2014;78:353-63.